B7-33: The Non-Oncogenic Alternative for Relaxin-2 Receptor Research
Explore B7-33: The Non-Oncogenic Alternative for Relaxin-2 Receptor Research. Discover how this single-chain peptide supports selective RXFP1 signalling. B7-33 is a synthetic single-chain peptide that selectively activates the relaxin-2 receptor (RXFP1) to clear excess scar tissue without triggering…